BR9809478A - Uso de um oligossacarìdeo sintético, processos para prevenção de coagulação sanguìnea em um mamìfero e para prevenção de coagulação sanguìnea e um circuito sanguìneo extracorpóreo, e, composição farmacêutica adaptada para prevenir coagulação sanguìnea em um circuito sanguìneo extracorpóreo - Google Patents

Uso de um oligossacarìdeo sintético, processos para prevenção de coagulação sanguìnea em um mamìfero e para prevenção de coagulação sanguìnea e um circuito sanguìneo extracorpóreo, e, composição farmacêutica adaptada para prevenir coagulação sanguìnea em um circuito sanguìneo extracorpóreo

Info

Publication number
BR9809478A
BR9809478A BR9809478-5A BR9809478A BR9809478A BR 9809478 A BR9809478 A BR 9809478A BR 9809478 A BR9809478 A BR 9809478A BR 9809478 A BR9809478 A BR 9809478A
Authority
BR
Brazil
Prior art keywords
blood clotting
preventing
clotting
extracorporeal
circuit
Prior art date
Application number
BR9809478-5A
Other languages
English (en)
Inventor
Jean Marc Herbert
Jacobus Christianus J Stiekema
Original Assignee
Akzo Nobel Nv
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sanofi Synthelabo filed Critical Akzo Nobel Nv
Publication of BR9809478A publication Critical patent/BR9809478A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

"USO DE UM OLIGOSSACARìDEO SINTéTICO, PROCESSOS PARA PREVENçãO DE COAGULAçãO SANGUìNEA EM UM MAMìFERO E PARA PREVENçãO DE COAGULAçãO SANGUìNEA EM UM CIRCUITO SANGUìNEO EXTRACORPóREO, E, COMPOSIçãO FARMACêUTICA ADAPTADA PARA PREVENIR COAGULAçãO SANGUìNEA EM UM CIRCUITO SANGUìNEO EXTRACORPóREO". A invenção refere-se ao uso de um oligossacarídeo sintético que é inibidor seletivo de fator Xa, atuando via antitrombina III, para a produção de um medicamento para prevenção de coágulo sanguíneo em pacientes com um circuito sanguíneo extracorpóreo.
BR9809478-5A 1997-05-27 1998-05-22 Uso de um oligossacarìdeo sintético, processos para prevenção de coagulação sanguìnea em um mamìfero e para prevenção de coagulação sanguìnea e um circuito sanguìneo extracorpóreo, e, composição farmacêutica adaptada para prevenir coagulação sanguìnea em um circuito sanguìneo extracorpóreo BR9809478A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201586 1997-05-27
PCT/EP1998/003174 WO1998053829A1 (en) 1997-05-27 1998-05-22 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits

Publications (1)

Publication Number Publication Date
BR9809478A true BR9809478A (pt) 2000-06-20

Family

ID=8228366

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809478-5A BR9809478A (pt) 1997-05-27 1998-05-22 Uso de um oligossacarìdeo sintético, processos para prevenção de coagulação sanguìnea em um mamìfero e para prevenção de coagulação sanguìnea e um circuito sanguìneo extracorpóreo, e, composição farmacêutica adaptada para prevenir coagulação sanguìnea em um circuito sanguìneo extracorpóreo

Country Status (12)

Country Link
US (3) US6391339B1 (pt)
EP (2) EP0984785B1 (pt)
JP (2) JP2002503270A (pt)
AT (1) ATE307596T1 (pt)
AU (1) AU8211398A (pt)
BR (1) BR9809478A (pt)
CA (1) CA2289522A1 (pt)
DE (1) DE69832066T2 (pt)
DK (1) DK0984785T3 (pt)
ES (1) ES2251090T3 (pt)
NO (1) NO325142B1 (pt)
WO (1) WO1998053829A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2289522A1 (en) * 1997-05-27 1998-12-03 Akzo Nobel Nv Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
FR2804328B1 (fr) 2000-01-27 2002-03-15 Hospal Ind Membrane semi-permeable non thrombogene et procede de fabrication
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
JP5925693B2 (ja) * 2009-12-01 2016-05-25 エクステラ・メディカル・コーポレーション 表面固定した多糖類を用いた、血液からのサイトカイン除去法
WO2013188073A1 (en) 2012-06-13 2013-12-19 Exthera Medical, Llc Use of heparin and carbohydrates to treat cancer
CA2928866C (en) 2013-11-08 2021-11-09 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
JP2017513636A (ja) 2014-04-24 2017-06-01 エクスセラ メディカル コーポレイション 高流量を用いて血液から細菌を除去するための方法
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
DE3008993A1 (de) * 1980-03-08 1981-10-01 Röhm Pharma GmbH, 6100 Darmstadt Pharmazeutische zubereitungen
US4331697A (en) * 1980-09-02 1982-05-25 Teijin Limited Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
US4801583A (en) * 1982-01-15 1989-01-31 Choay S.A. Oligosaccharides and their biological applications
JPS63218691A (ja) * 1987-03-09 1988-09-12 Rikagaku Kenkyusho 新規な５糖類化合物及びその製造法並びに抗凝血及び抗血栓剤
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
WO1993005825A1 (en) * 1991-09-20 1993-04-01 Baxter International Inc. Processes for reducing the thrombogenicity of biomaterials
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US6391369B1 (en) * 1996-03-27 2002-05-21 Bunge Foods Corporation Selectively hydrogenated high oleic oil compositions and process
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
CA2289522A1 (en) * 1997-05-27 1998-12-03 Akzo Nobel Nv Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits

Also Published As

Publication number Publication date
DE69832066D1 (de) 2005-12-01
US20070197637A1 (en) 2007-08-23
NO325142B1 (no) 2008-02-11
NO995800L (no) 1999-11-26
US6391339B1 (en) 2002-05-21
CA2289522A1 (en) 1998-12-03
JP2010013455A (ja) 2010-01-21
EP0984785A1 (en) 2000-03-15
ES2251090T3 (es) 2006-04-16
DE69832066T2 (de) 2006-07-13
ATE307596T1 (de) 2005-11-15
WO1998053829A1 (en) 1998-12-03
AU8211398A (en) 1998-12-30
NO995800D0 (no) 1999-11-26
EP1593380A3 (en) 2008-06-11
EP1593380A2 (en) 2005-11-09
JP2002503270A (ja) 2002-01-29
DK0984785T3 (da) 2006-01-30
EP0984785B1 (en) 2005-10-26
US20020040012A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
ATE425139T1 (de) Benzamidinderivate
DE69005347D1 (de) Absaugkanüle für chirurgische Zwecke, insbesondere für Fettabsaugung.
NL194779B (nl) Gestabiliseerd vrijdragend patiÙnttafelstelsel.
DK146289D0 (da) Fremgangsmaade til saenkning af blodtrykket
IS4523A (is) Speglunarskuggaefni, sem helst lengi í blóði, tilsjúkdómsgreininga
CY1110582T1 (el) Νεες φαρμακευτικες συνθεσεις με βαση αλατα τιοτροπιου και κικλεσονιδη
DK0932398T3 (da) Anvendelse af topiramat eller derivater deraf til fremstilling af et lægemiddel til behandling af maniodepressive bipolære forstyrrelser
DK0558529T3 (da) Farmaceutisk præparat til behandling af forlænget koagulationstid
ATE243196T1 (de) Piperidine und pyrrolidine
YU63699A (sh) Preparati za tretiranje i prevenciju arterijske tromboze i korišćenje inhibitora faktora xa samog ili u kombinaciji sa plateletnim antiagregacionim agensom
DK0503887T3 (da) Fremme af sårheling med 15-ketoprostaglandinforbindelser
DK0825857T3 (da) Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse
BR9809478A (pt) Uso de um oligossacarìdeo sintético, processos para prevenção de coagulação sanguìnea em um mamìfero e para prevenção de coagulação sanguìnea e um circuito sanguìneo extracorpóreo, e, composição farmacêutica adaptada para prevenir coagulação sanguìnea em um circuito sanguìneo extracorpóreo
ATE307497T1 (de) Pharmazeutische zusammensetzung
DE69821498D1 (de) Verwendung von amifostin
DE68905573D1 (de) Leicht absorbierbare nb-818 enthaltende arzneizubereitung.
FI952593A0 (fi) Hyytymistä estävä aine
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
DK694188D0 (da) Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
PT1069885E (pt) Solucao oftalmica que compreende glicogenio
BR0113478A (pt) Mecanismo especìfico para inibição de adesão de plaqueta a colágeno
TR24739A (tr) Ipliklere veya dokunmus yuezey olusumlarina mahsus sulu alkalik muamele maddeleri
DK301190D0 (da) Bioforenelige, stof-specifikke reagenser til behandling af fysiologiske vaesker
SE8802040D0 (sv) New use

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: SANOFI-SYNTHELABO (FR)

B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO REQUISEITO DE ATIVIDADE INVENTIVA ( ATIGO 8O COMBINADO COM ARTIGO 13 DA LEI 9279/96

B12B Appeal against refusal [chapter 12.2 patent gazette]